Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

WHO urges to address the high price and limited production of antibody combination for COVID-19

The World Health Organization (WHO) welcomes the addition of another therapeutic to the world's arsenal against COVID-19, but urges producing companies and governments to address the high price and limited production of the Regeneron antibody combination and ensure safe and appropriate handling of the medicine.

27 Sep 2021

Global leaders underline their commitment to ensure equitable access to COVID-19 vaccines

Global leaders attending the Global COVID-19 Summit hosted by the United States have again underlined their commitment to ensuring equitable access to COVID-19 vaccines for all countries through COVAX – noting that equitable access is essential to end the acute stage of the pandemic.

27 Sep 2021

Scientists develop 'elite' antibodies capable of defeating coronavirus variants at extremely low dosage

Japanese scientists created "elite" antibodies that defeat various coronavirus variants even at an extremely low dose through a new method that accelerated the months-long process of finding such extraordinary antibody candidates to just ten days.

27 Sep 2021

Novel antibody candidate shows potent binding to diverse SARS-CoV-2 variant mutations

Twist Bioscience Corporation (Nasdaq: TWST) today reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to diverse SARS-CoV-2 variant mutations, including strains with the E484K, N501Y, D614G, Y453F and K417N mutations in pseudovirus assays, indicating this therapeutic antibody may be effective in treating many strains of COVID-19.

25 Sep 2021

3D-printed vaccine patch provides greater protection than a typical vaccine shot

Scientists at Stanford University and the University of North Carolina at Chapel Hill have created a 3D-printed vaccine patch that provides greater protection than a typical vaccine shot.

25 Sep 2021

Video game style technology could reduce rehabilitation time for patients with stroke, dystonia and sports injuries

Academic and engineering experts from the University of Strathclyde and the National Manufacturing Institute Scotland, have teamed up with UK and European partners to reduce rehabilitation times for patients with stroke, dystonia and sports injuries by up to 30% using video game style technology.

25 Sep 2021

Inactivated egg-based Newcastle disease virus vaccine expressing SARS-CoV-2 spike protein

A new study presents initial results from a randomized, placebo-controlled phase 1/2 trial in Thailand.

24 Sep 2021

Design of mRNA vaccines to combat COVID-19

A recent review study discusses fundamental concepts in the successful delivery of nucleic acids in therapeutics.

23 Sep 2021

Researchers to develop sensor-containing super-smart textiles for remote health monitoring

The global population recently reached 7.8 billion, among which almost 15% suffer from disabilities mainly caused by ageing and chronic diseases.

23 Sep 2021

Public health experts ‘flabbergasted’ that Biden still hasn’t picked an FDA chief

President Joe Biden's failure to name someone to lead the Food and Drug Administration, more than 10 months after the election, has flummoxed public health experts who say it's baffling for the agency to be without a permanent leader during a national health crisis.

22 Sep 2021

Repeated injury to the epithelial tissue of airways causes "biological aging" of stem cells

Are prematurely aged or overworked stem cells a significant factor in chronic lung disease? Findings of a study just released in STEM CELLS Translational Medicine (SCTM) say this is likely so.

22 Sep 2021

Careful pipetting reduces the stress on cells in culture

Cell viability, defined as the proportion of live cells in a sample, is a fundamental consideration in all cell culture techniques.

From INTEGRA Biosciences 21 Sep 2021

International organizations, vaccine manufacturers discuss strategies to improve access to COVID-19 vaccines

The heads of the International Monetary Fund, World Bank Group, World Health Organization and World Trade Organization met with the CEOs of leading vaccine manufacturing companies to discuss strategies to improve the access to COVID-19 vaccines, especially in low- and lower middle-income countries and in Africa.

20 Sep 2021

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

In contrast to intramuscular vaccines, only nasal vaccines are able to block the virus in the nose by inducing local immunity in the nasal mucosa, i.e. the portal of entry and multiplication of the virus.

18 Sep 2021

Multi-million government fund given to 21 projects to propel innovation across the UK

Regulators are clearing the runway for drones to transport vaccines and other live-saving drugs, in a ground-breaking venture funded by government.

16 Sep 2021

Health leaders issue an urgent call for vaccine equity globally and in Africa

WHO Director-General Dr Tedros Adhanom Ghebreyesus and a group of global health leaders today issued an urgent call for vaccine equity globally and in Africa in particular.

14 Sep 2021

Cholesterol appears to play a key role in the development of Alzheimer’s disease

Cholesterol manufactured in the brain appears to play a key role in the development of Alzheimer's disease, new research indicates.

14 Sep 2021

New statement on COVAX global supply forecast for 2021 and early 2022

Twelve months ago, the world came together to support COVAX, a multilateral initiative aimed at guaranteeing global access to life-saving COVID-19 vaccines.

10 Sep 2021

UC San Diego receives $12.25 million NIH grant to improve epilepsy treatment

The National Institutes of Health has awarded a $12.25 million grant to the University of California San Diego to develop and enhance brain-sensing and brain-stimulating platform technologies to enable treatment of drug-resistant epilepsy.

10 Sep 2021

3D-printed origami technology to aid in the fight against COVID-19

Researchers in Simon Fraser University’s Additive Manufacturing Lab are replicating a distinctive artform—the subtle folding of origami—to create 3D printable technologies to aid in the fight against COVID-19, and help doctors to identify and diagnose various health conditions.

9 Sep 2021

Manufacturing News and Research

Further Reading

WHO urges to address the high price and limited production of antibody combination for COVID-19

Global leaders underline their commitment to ensure equitable access to COVID-19 vaccines

Scientists develop 'elite' antibodies capable of defeating coronavirus variants at extremely low dosage

Novel antibody candidate shows potent binding to diverse SARS-CoV-2 variant mutations

3D-printed vaccine patch provides greater protection than a typical vaccine shot

Video game style technology could reduce rehabilitation time for patients with stroke, dystonia and sports injuries

Inactivated egg-based Newcastle disease virus vaccine expressing SARS-CoV-2 spike protein

Design of mRNA vaccines to combat COVID-19

Researchers to develop sensor-containing super-smart textiles for remote health monitoring

Public health experts ‘flabbergasted’ that Biden still hasn’t picked an FDA chief

Repeated injury to the epithelial tissue of airways causes "biological aging" of stem cells

Careful pipetting reduces the stress on cells in culture

International organizations, vaccine manufacturers discuss strategies to improve access to COVID-19 vaccines

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

Multi-million government fund given to 21 projects to propel innovation across the UK

Health leaders issue an urgent call for vaccine equity globally and in Africa

Cholesterol appears to play a key role in the development of Alzheimer’s disease

New statement on COVAX global supply forecast for 2021 and early 2022

UC San Diego receives $12.25 million NIH grant to improve epilepsy treatment

3D-printed origami technology to aid in the fight against COVID-19

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®